$2.9B
Reported book value
| # | Security | Shares | Share Δ QoQ | Value | % of book |
|---|---|---|---|---|---|
| 1 | KRYS Krystal Biotech Inc | 939,254 | −18.5% | $349M | 12.0% |
| 2 | CELC Celcuity Inc | 1.7M | +32.7% | $178M | 6.1% |
| 3 | TGTX Tg Therapeutics Inc | 2.9M | −27.3% | $161M | 5.5% |
| 4 | PODD Insulet Corp | 1.0M | +86.5% | $160M | 5.5% |
| 5 | NVCR Novocure Ltd | 9.9M | −5.5% | $150M | 5.2% |
| 6 | UTHR United Therapeutics Corp Del | 225,587 | +20.5% | $122M | 4.2% |
| 7 | INSPIRE MED SYS INC Inspire Med Sys Inc | 1.9M | +235.1% | $86M | 3.0% |
| 8 | RIGL Rigel Pharmaceuticals Inc | 1.8M | +18335.0% | $72M | 2.5% |
| 9 | ANIP Ani Pharmaceuticals Inc | 867,760 | +5.8% | $72M | 2.5% |
| 10 | BBNX Beta Bionics Inc | 4.4M | +0.9% | $69M | 2.4% |
| 11 | VCEL Vericel Corp | 1.5M | −42.8% | $65M | 2.2% |
| 12 | PRAX Praxis Precision Medicines I | 177,517 | −46.3% | $59M | 2.0% |
| 13 | GERN Geron Corp | 42.8M | +3.1% | $55M | 1.9% |
| 14 | ALKS Alkermes Plc | 1.0M | −47.8% | $54M | 1.9% |
| 15 | ERAS Erasca Inc | 2.7M | — | $49M | 1.7% |
| 16 | NPCE Neuropace Inc | 2.9M | −0.7% | $46M | 1.6% |
| 17 | PGNY Progyny Inc | 1.6M | −22.5% | $46M | 1.6% |
| 18 | INDIVIOR PHARMACEUTICALS INC Indivior Pharmaceuticals Inc | 1.1M | −16.5% | $44M | 1.5% |
| 19 | PBLS Parabilis Medicines Inc | 1.5M | — | $40M | 1.4% |
| 20 | FOCL Edap Tms S A | 7.3M | +0.0% | $38M | 1.3% |
| 21 | GMED Globus Med Inc | 468,922 | −35.7% | $37M | 1.3% |
| 22 | RCUS Arcus Biosciences Inc | 1.2M | +158.6% | $36M | 1.2% |
| 23 | SNDX Syndax Pharmaceuticals Inc | 1.6M | −5.7% | $36M | 1.2% |
| 24 | NRIX Nurix Therapeutics Inc | 1.5M | +56.2% | $36M | 1.2% |
| 25 | LEGN Legend Biotech Corp | 1.2M | — | $35M | 1.2% |
| 26 | JBIO Jade Biosciences Inc | 1.6M | +94.6% | $34M | 1.2% |
| 27 | UNH Unitedhealth Group Inc | 80,000 | — | $33M | 1.1% |
| 28 | AVTX Avalo Therapeutics Inc | 1.7M | +274.4% | $31M | 1.1% |
| 29 | URGN Urogen Pharma Ltd | 829,810 | +14.1% | $31M | 1.1% |
| 30 | MBX Mbx Biosciences Inc | 515,279 | +188.0% | $28M | 1.0% |
| 31 | PALI Palisade Bio Inc | 13.1M | — | $27M | 0.9% |
| 32 | PHVS Pharvaris N V | 730,907 | +4.1% | $25M | 0.9% |
| 33 | ORGO Organogenesis Hldgs Inc | 10.1M | +0.5% | $25M | 0.8% |
| 34 | SUPN Supernus Pharmaceuticals | 520,000 | — | $24M | 0.8% |
| 35 | PRCT Procept Biorobotics Corp | 1.0M | +526.9% | $23M | 0.8% |
| 36 | TNGX Tango Therapeutics Inc | 709,000 | +57.6% | $22M | 0.8% |
| 37 | IKT Inhibikase Therapeutics Inc | 10.9M | +0.0% | $22M | 0.8% |
| 38 | TRVI Trevi Therapeutics Inc | 1.2M | −27.2% | $22M | 0.8% |
| 39 | BMRN Biomarin Pharmaceutical Inc | 375,572 | −42.3% | $21M | 0.7% |
| 40 | LIVN Livanova Plc | 254,957 | −56.2% | $21M | 0.7% |
| 41 | ARGX Argenx Se | 19,955 | +470.1% | $19M | 0.6% |
| 42 | NVCT Nuvectis Pharma Inc | 1.0M | — | $18M | 0.6% |
| 43 | CAPR Capricor Therapeutics Inc | 761,737 | — | $18M | 0.6% |
| 44 | EWTX Edgewise Therapeutics Inc | 450,889 | −68.9% | $18M | 0.6% |
| 45 | PRLD Prelude Therapeutics Inc | 3.4M | — | $18M | 0.6% |
| 46 | XENE Xenon Pharmaceuticals Inc | 267,000 | −8.6% | $16M | 0.6% |
| 47 | CCCC C4 Therapeutics Inc | 3.4M | −11.2% | $16M | 0.5% |
| 48 | KINIKSA PHARMACEUTICALS INTL Kiniksa Pharmaceuticals Intl | 246,353 | −52.7% | $16M | 0.5% |
| 49 | KIDS Orthopediatrics Corp | 732,144 | +19.0% | $14M | 0.5% |
| 50 | AVALYN PHARMACEUTICALS INC Avalyn Pharmaceuticals Inc | 419,000 | — | $14M | 0.5% |